Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

Safeguarding health and well-being for employees – the value of occupational health services

Medical Communications | Chartered Institute of Personnel and Development, Society of Occupational Medicine, employee health and well-being, occupational health, workplace sickness absence levels

With workplace sickness absence levels stuck at record levels, employers need to step-change how they think about and manage employee …

Feature

Men’s health – a new report from the Department of Health and Social Care

Medical Communications | Men's Health Strategy, Men's mental health, UK Department of Health and Social Care, medical communications, medical education, mental health

The UK Department of Health and Social Care has published a new report entitled Men’s health: a strategic vision for …

Feature

Healing the fracture in the system: the case for universal fraction liaison services access

Medical Communications, Research and Development | Osteoporosis

By Tina Backhouse In 2024, the UK government committed to achieving 100% coverage of Fracture Liaison Services (FLS)across the NHS …

Feature

Five Facts about antimicrobial resistance

Medical Communications | Antimicrobial resistance (AMR), Five Facts

1 Antimicrobial resistance (AMR) is when bacteria, viruses, fungi and parasites no longer respond to antimicrobial agents such as antibiotics.1 Around 35,000 …

Feature

A community-first future: which pathways will get us there?

Business Services | Gateway to Local Adoption, NHS, Visions4Health, pharmacy

In the final Gateway to Local Adoption article of 2025, Visions4Health caught up with Julian Wenman, senior operations manager in …

Feature

Von Willebrand disease – increasing awareness and access to vital care

Medical Communications, Research and Development | European Medicines Association, Haematology, Takeda, Von Willebrand Disease, clinical trials, disease awareness

Pharmafile talks to Anthea Cherednichenko, Vice President Franchise Head Haematology and Transplant at Takeda about Von Willebrand disease, its causes …

Feature

Rethinking oncology trial endpoints with generalised pairwise comparisons

Research and Development | EMA, FDA, Oncology, One2Treat, clinical trials, generalised pairwise comparisons, net treatment benefit, oncology

For decades, oncology trials have been anchored to a familiar set of endpoints. Overall survival (OS) and progression-free survival (PFS) …

Feature

The Pharma Files: with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust

Medical Communications, Research and Development | Corporate, NHS, The Pharma Files, healthcare professionals, patient care, patients

Pharmafile chats with Dr Ewen Cameron, Chief Executive of West Suffolk NHS Foundation Trust, about the best parts of his …

Feature

Five Facts about men’s mental health

Medical Communications | Five Facts, mental health, men’s mental health

1 While only 15.4% of men are diagnosed with a common mental health condition (CMHC’s) in the UK (compared to …

Feature

Is this an Oppenheimer moment for the life sciences industry?

Business Services, Market Access, Market Access Consultancy, Sales and Marketing | NHS, Visions4Health

By Sabina Syed, Managing Director at Visions4Health In the history of science, few initiatives demonstrate the magnitude of coordinated effort …

Feature
Thought Leadership

Turning a 10-Year Vision into a 10-Year Plan

Business Services, Market Access, Market Access Consultancy | Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy

In the sixth of the Gateway to Local Adoption series, Visions4Health’s Head of Client Services, Jonny Savage, shares his views …

Feature

Uterine fibroids and the cost of silence

Medical Communications, Research and Development | Reproductive health, gynaecological conditions, menstruation, uterine fibroids

By Tina Backhouse Stigma and shame Every month, most women on the planet have a period. It’s completely natural – …

Feature

Novel excipients: the key to unlocking drug innovation

Business Services | Lubrizol, Pharmacy

ADVERTORIAL, IN ASSOCIATION WITH LUBRIZOL Meera Raghuram, Director of Regulatory and Sustainability Strategy at Lubrizol, explores how formulators can overcome …

Feature
Thought Leadership

The Pharma Files: With Colin Williams from Astellas Pharma

Medical Communications, Research and Development | Astellas Pharma, Corporate, The Pharma Files, pm society

Pharmafile chats with Colin Williams, Head of Marketing Excellence, Global Capabilities, Learning & Development at Astellas Pharma about the best …

Feature

How can optichannel engagement drive return on investment across the product life cycle?

Business Services, Consultancy | Corporate, PharmaForceIQ, Pharmacy, chief strategy officer, optichannel engagement

HCPs and patients are demanding personalised, streamlined experiences. Hemal Somaiya, Chief Strategy Officer, PharmaForceIQ, discusses how optichannel engagement offers a …

Feature
Load more Feature Articles
The Gateway to Local Adoption Series

Latest content

Evotec and Bayer announce new kidney disease study

December 11, 2025

Actithera appoints Darshan Dalal as Chief Medical Officer

December 11, 2025

Pace appoints Ken Beyer as CEO

December 10, 2025

EpilepsyGTx raises $33m for focal refractory epilepsy gene therapy

December 10, 2025

Breast Cancer Now study to explore personalised drug doses

December 9, 2025